Of infertile couples, approximately one-third feature male factor issues. A subset of male factor infertility is attributable to congenital or acquired pediatric urologic conditions, and patients with these disorders are often challenging to treat. Prior to the development of in vitro fertilization (IVF) in the 1970s and intracytoplasmic sperm injection (ICSI) in 1992 [1], many forms of infertility due to pediatric urologic conditions were untreatable. These technologies have enabled many previously infertile men to father children, but the effectiveness of these techniques in men with pediatric urologic disorders has never been systematically examined. In this review we provide a contemporary survey of the fertility status of men with pediatric urologic disorders in light of advances in assisted reproductive technology (ART). We examine currently available treatments as well as developing technologies and discoveries that may apply to pediatric urologic disorders.
KeywordsInfertility; male; urologic diseases; child; azoospermia; birth defects; ICSI The Society for Assisted Reproduction (SART) defines assisted reproductive techniques as any procedure requiring manipulation of gametes or embryos in vitro. By this definition, IVF is included but intrauterine insemination (IUI) is excluded.IVF involves controlled ovarian stimulation followed by egg retrieval, in vitro fertilization and embryo transfer to the uterus. The goal of hormonal stimulation during IVF is to develop multiple mature follicles so that enough eggs are retrieved to counteract the inherent inefficiencies of fertilization, and the limitations of in vitro embryo culture. The process by which the menstrual cycle is regulated during ART procedures is controlled ovarian stimulation. Following ovarian stimulation and ovulation induction, egg retrieval is performed transvaginally by ultrasound-guided follicle aspiration. On the same day, a semen sample is